Heparin Hyperkalemia Mechanism

Heparin, a widely used anticoagulant, is known for its efficacy in preventing and treating thrombotic disorders. However, one of its lesser-known side effects is its potential to induce hyperkalemia, a condition characterized by elevated potassium levels in the blood. In this blog post, we will delve into the mechanism behind heparin-induced hyperkalemia, its risk factors, and strategies for prevention and management.

: Aldosterone normally acts on the principal cells of the collecting duct in the kidney to increase the expression and activity of epithelial sodium channels (ENaC) and the Na⁺/K⁺-ATPase pump . This promotes sodium reabsorption and, crucially, potassium secretion into the urine. When aldosterone is suppressed, potassium excretion decreases. heparin hyperkalemia mechanism

Potassium levels typically reach their highest point between 3 to 5 days of treatment. Heparin, a widely used anticoagulant, is known for

Heparin-induced hyperkalemia is an under-recognized but common metabolic complication occurring in about treated with heparin. The primary mechanism is a direct suppression of aldosterone production in the adrenal glands, which impairs the kidneys' ability to excrete potassium . Pathophysiological Mechanism : Aldosterone normally acts on the principal cells

potassium retention in the blood. Who is at risk? While most people can compensate, it becomes a real concern for patients with: Chronic Kidney Disease (CKD) Diabetes Mellitus Those already taking ACE inhibitors or potassium-sparing diuretics. Clinical Pearl: This effect can happen with both unfractionated heparin and LMWH, and typically kicks in within 3 to 7 days of starting therapy. Would you like to see a comparison of how

To minimize the risk of heparin-induced hyperkalemia: